Biogen soars on beat, positive Alzheimers trial results

Biogen is up on news its submitting to the Food and Drug Administration an experimental Alzheimer's drug. Yahoo Finance’s Dan Roberts, Anjalee Khemlani and Scott Gamm discuss on YFi AM.